Masna A. Rai
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group Study.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 09, 2025
Efficacy and Safety of Biosimilar AVT05 Versus Reference Product Golimumab in Combination with Methotrexate in Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results of a Randomized, Parallel-Group, Double-Blind Study.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 07, 2025
A randomized, double blind, parallel design, repeat dose, 2-arm, multicenter study comparing the efficacy, safety, immunogenicity, and pharmacokinetic profiles of a denosumab biosimilar, AVT03, in postmenopausal women with osteoporosis.
Journal: Expert opinion on biological therapy
Published: July 23, 2025
A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degeneration.
Journal: Expert opinion on biological therapy
Published: June 13, 2025
A randomized, double-blind, single dose, parallel group, 2-arm study assessing the pharmacokinetic similarity, safety, tolerability, and immunogenicity profiles of biosimilar candidate AVT03 (70 mg/mL) in healthy male adults.
Journal: Expert opinion on investigational drugs
Published: May 13, 2025
A randomized, double-blind, single dose, parallel group, 2-arm study assessing the pharmacokinetic similarity, pharmacodynamic, safety, tolerability, and immunogenicity profiles of biosimilar candidate AVT03 (60 mg/mL) in healthy male adults.
Journal: Expert opinion on investigational drugs
Published: May 13, 2025
Achievements and gaps in projection studies on the temperature-attributable health burden: Where should we be headed?
Journal: Frontiers in epidemiology
Published: November 09, 2023
Joint effect of heat and air pollution on mortality in 620 cities of 36 countries.
Journal: Environment international
Published: June 10, 2023
Assessment of short-term heat effects on cardiovascular mortality and vulnerability factors using small area data in Europe.
Journal: Environment international
Published: April 21, 2023
Temporal variation in the association between temperature and cause-specific mortality in 15 German cities.
Journal: Environmental research
Published: November 07, 2022
Heat-related cardiorespiratory mortality: Effect modification by air pollution across 482 cities from 24 countries.
Journal: Environment international
Published: August 31, 2022
Future temperature-related mortality considering physiological and socioeconomic adaptation: a modelling framework.
Journal: The Lancet. Planetary health
Published: December 21, 2021
Last Updated: 09/26/2026